Fig. 1.

Kaplan–Meier curve of overall survival (a) and hazard ratios of overall survival (b) in patients with leiomyosarcoma. CI confidence interval, ECOG PS Eastern Cooperative Oncology Group performance score, HR hazard ratio (eribulin to dacarbazine), based on a Cox regression model including treatment as a covariate and stratification factors of geographic region and number of prior chemotherapy regimens, LMS leiomyosarcoma, STS soft tissue sarcoma. ^a Region 1 = USA and Canada; Region 2 = Western Europe, Australasia, and Israel; Region 3 = Eastern Europe, Latin America, and Asia